Neumann J, Hofmann B, Gergs U (2024b) Positive inotropic effects of glucose-dependent insulinotropic polypeptide in the human atrium
Reducing appetite through signals to the brain
I just dont quite know how smooth its going to be. In fall 2025, about 5 million US adults ages 65 and above the population that is covered by Medicare were taking a GLP-1 drug for weight loss or a chronic condition such as diabetes, according to a KFF Health survey
Shipping considerations matter during Canadian winters
Their 15+ years of behavioral psychology expertise shows up in daily CBT-based lessons, food logging, 1:1 coaching, community groups, and GLP-1 Companion tools
Mice were euthanized on days 27 and 28 of the study